Close Close Comment Creative Commons Donate Email Add Email Facebook Instagram Facebook Messenger Mobile Nav Menu Podcast Print RSS Search Secure Twitter WhatsApp YouTube
Stand up for journalism that holds the powerful to account.

Prominent Texas Surgeon Sues ProPublica and the Houston Chronicle

Bud Frazier, a pioneer in the development of artificial hearts, filed a libel suit alleging he was “falsely” portrayed in two articles exploring alleged lapses in research and ethical practices.

This story was co-published with the Houston Chronicle.

A Texas heart surgeon whose practices recently have been the subject of stories by ProPublica and the Houston Chronicle filed a lawsuit this week against the news organizations alleging defamation.

Dr. O.H. “Bud” Frazier brought the suit in Harris County (Texas) District Court, challenging a May story that examined concerns with the doctor’s conduct, as well as one last month addressing criticism of the first article. The suit also names the stories’ authors, reporters Charles Ornstein of ProPublica and Mike Hixenbaugh of the Chronicle, as defendants.

Frazier, a famed heart transplant surgeon at Baylor St. Luke’s Medical Center and the Texas Heart Institute, asserts that the articles included errors and misleading statements “calculated to falsely portray Dr. Frazier as an inhumane physician.”

“We have seen the complaint in this case, although we have not yet been served,” said Richard Tofel, president of ProPublica. “We think the lawsuit lacks merit, and we intend to defend it vigorously.”

Nancy Barnes, executive vice president and editor of the Chronicle, said: “The Houston Chronicle stands behind the reporters on this story, and our journalism, and we will defend our work vigorously.”

The articles involving Frazier were part of a larger series, “Heart Failure,” jointly reported by ProPublica and the Chronicle.

The first article about Frazier, the transplant program’s founding surgeon, revealed that he had been accused of violating research rules and skirting ethical guidelines. A hospital investigation found that Frazier and his team implanted experimental heart pumps in patients who didn’t meet medical criteria for clinical trials. The findings were viewed as serious enough that St. Luke’s reported the research violations to the federal government and repaid millions of dollars to Medicare.

In his lawsuit, Frazier calls the decision to repay the money “ill-advised” and criticizes St. Luke’s findings of research violations. He also says that he was motivated by saving lives, not by money.

Other stories in the series detailed how St. Luke’s heart transplant program has in recent years performed an outsized number of transplants that resulted in deaths or unusual complications.

St. Luke’s temporarily suspended heart transplants in June to review two recent patient deaths; it reopened the program two weeks later. Medicare has since announced that it intends to cut off funding for St. Luke’s heart transplant program in August, citing shortcomings that have not been corrected.

Filed under:

Protect Independent Journalism

This story you’ve just finished was funded by our readers. We hope it inspires you to make a gift to ProPublica so that we can publish more investigations like this one that hold people in power to account and produce real change.

ProPublica is a nonprofit newsroom that produces nonpartisan, evidence-based journalism to expose injustice, corruption and wrongdoing. We were founded over 10 years ago to fill a growing hole in journalism: Newsrooms were (and still are) shrinking, and legacy funding models are failing. Deep-dive reporting like ours is slow and expensive, and investigative journalism is a luxury in many newsrooms today — but it remains as critical as ever to democracy and our civic life. More than a decade (and six Pulitzer Prizes) later, ProPublica has built one of the largest investigative newsrooms in the country. Our work has spurred reform through legislation, at the voting booth and inside our nation’s most important institutions.

Your donation today will help us ensure that we can continue this critical work. From the climate crisis, to racial justice, to wealth inequality and much more, we are busier than ever covering stories you won’t see anywhere else. Make your gift of any amount today and join the tens of thousands of ProPublicans across the country, standing up for the power of independent journalism to produce real, lasting change. Thank you.

Donate Now

Portrait of Ryan Gabrielson

Ryan Gabrielson

Ryan Gabrielson is a reporter for ProPublica covering healthcare and federal regulation of the pharmaceutical industry, currently focused on the COVID-19 vaccines.

Latest Stories from ProPublica

Current site Current page